Innovia Medical announced today that it acquired Lacrimedics and its occlusion therapy devices for treating dry eye disease.
DuPont, Washington-based Lacrimedics’ ophthalmic product line includes the dissolvable VisiPlug and the Opaque Herrick lacrimal plugs, and the ComfortTip and AccuFlo punctual occluders.
Founded in 1984, Lacrimedics pioneered the development of collagen plugs for the lacrimal efficiency test in the 1980s, which provides a simple method to diagnose dry eye disease and determine whether a patient will respond favorably to occlusion therapy, according to a news release.
“The addition of Lacrimedics products will allow us to provide ophthalmic customers with comprehensive occlusion therapy options,” Innovia Medical CEO Terry Meredith said in the release. “This acquisition helps to strengthen Innovia’s portfolio of solutions designed with both medical professionals and their patients in mind.”
“We are excited for the future and look forward to expanding our ability to positively impact patient care with Innovia Medical,” Lacrimedics President Robert Herrick, II, said in the release.